From: Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
Number of samples (percentage)
Pathological T-category
pT2
57 (41 %)
pT3 and pT4
72 (52 %)
Unknown
9 (7 %)
Pathological Gleason score
≤ 6
81 (58 %)
7
27 (20 %)
≥ 8
22 (16 %)
8 (6 %)